Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1597687
Reference Type
Journal Article
Title
Development of probiotic tablets using microparticles: viability studies and stability studies
Author(s)
E Silva, JP; Sousa, SC; Costa, P; Cerdeira, E; Amaral, MH; Lobo, JS; Gomes, AM; Pintado, MM; Rodrigues, D; Rocha-Santos, T; Freitas, AC
Year
2013
Is Peer Reviewed?
Yes
Journal
AAPS PharmSciTech
ISSN:
1530-9932
Volume
14
Issue
1
Page Numbers
121-127
Language
English
PMID
23233282
DOI
10.1208/s12249-012-9898-9
Web of Science Id
WOS:000319798100015
Abstract
Alternative vectors to deliver viable cells of probiotics, to those conferring limited resistance to gastrointestinal conditions, still need to be sought. Therefore the main goal of the study was to develop tablets able to protect entrapped probiotic bacteria from gastric acidity, thus providing an easily manufacturing scale-up dosage form to deliver probiotics to the vicinity of the human colon. Whey protein concentrate microparticles with Lactobacillus paracasei L26 were produced by spray-drying and incorporated in tablets with cellulose acetate phthalate and sodium croscarmellose. The viability of L. paracasei L.26 throughout tableting as well as its gastric resistance and release from the tablets were evaluated. Storage stability of L. paracasei L26 tablets was also performed by evaluation of viable cells throughout 60 days at 23°C and 33% relative humidity. A decrease of approximately one logarithmic cycle was observed after the acid stage and the release of L. paracasei L26 from the tablets occurred only after 4 h in the conditions tested. Microencapsulated L. paracasei L26 in tablets revealed some susceptibility to the storage conditions tested since the number of viable cells decreased 2 log cycles after 60 days of storage. However, the viability of L. paracasei L26 after 45 days of storage did not reveal significant susceptibility upon exposure to simulated gastrointestinal conditions. The developed probiotic tablets revealed to be potential vectors for delivering viable cells of L. paracasei L26 and probably other probiotics to persons/patients who might benefit from probiotic therapy.
Keywords
colonic drug delivery; Lactobacillus paracasei; microencapsulation; release studies; tableting
Tags
IRIS
•
Phthalates – Targeted Search for Epidemiological Studies
Source – all searches
Pubmed
WOS
Excluded
Source – no date limit through June 2013 (Private)
Pubmed
Source - Dec 2013 Update (Private)
WOS
Source - Jun 2014 Update (Private)
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity